Stacey Gabriel, Ph.D.
Executive Vice President of Platforms and Scientific Execution, Institute Scientist
Stacey Gabriel is the executive vice president, platforms and scientific execution, at Broad Institute of MIT and Harvard, and has led platform development, execution, and operation since the institute’s founding in 2003. She is also an institute scientist and serves on the institute’s Executive Leadership Team.
Gabriel is widely recognized as a leader in genomics technology and application to foundational research programs. Her early work was foundational to the International HapMap Project. She has led the Broad Institute’s contributions to numerous flagship resource building programs in human genetics including the 1000 Genomes Project, The Cancer Genome Atlas (TCGA), and the TOPMed program. She is principal investigator of the Broad Institute All of Us (AoU) Genomics Center, and serves on the AoU Program Steering Committee.
In response to the COVID-19 pandemic, Gabriel led the development and execution of Broad's viral diagnostic and sequencing effort. The lab rapidly became the largest single testing lab in New England and delivered almost 38 million diagnostic test results in a three year period. For the work she was recognized by the Boston Globe as a “Bostonian of the Year” in 2020.
She has been recognized by Clarivate Analytics as one of the most highly cited scientists in molecular biology and genetics in the world six years in a row and recently named on the "Best Female Scientists in the World," ranking 22nd.
Gabriel received her B.S. in molecular biology from Carnegie Mellon University and Ph.D. in human genetics from Case Western Reserve University.
Casey Atkins Photography